Ernexa Therapeutics Inc. Common Stock (ERNA) is a publicly traded Healthcare sector company. As of May 20, 2026, ERNA trades at $11.20 with a market cap of $14.29M and a P/E ratio of -4.92. ERNA moved -8.20% today. Year to date, ERNA is -60.52%; over the trailing twelve months it is -86.72%. Its 52-week range spans $3.18 to $558.75. Analyst consensus is buy with an average price target of $30.00. Rallies surfaces ERNA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Ernexa Therapeutics Inc. Common Stock (ERNA) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ERNA moved -8.20% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $11.20 |
| Market Cap | $14.29M |
| P/E Ratio | -4.92 |
| EPS | $-2.24 |
| Dividend Yield | 0.00% |
| 52-Week High | $558.75 |
| 52-Week Low | $3.18 |
| Volume | 3.52K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-14.08M |
| Gross Margin | 0.00% |
1 analysts cover ERNA: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $30.00.